Iradimed (IRMD) Revenue (2013 - 2026)

Iradimed (IRMD) has 14 years of Revenue data on file, last reported at $22.0 million in Q1 2026.

• Revenue for Q1 2026 came in at $22.0 million, up 12.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.3 million (up 14.81% YoY), and the FY2025 annual result was $83.8 million, up 14.43% from the prior year.
• Revenue fell to $22.0 million in Q1 2026 per IRMD's latest filing, from $22.7 million in the prior quarter.
• Over five years, Revenue peaked at $22.7 million in Q4 2025 and troughed at $12.3 million in Q1 2022.
• A 5-year average of $17.5 million and a median of $17.6 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue jumped 33.46% in 2022, then advanced 10.87% in 2025.
• A 5-year view of Revenue shows it stood at $14.9 million in 2022, then rose by 17.42% to $17.5 million in 2023, then rose by 11.1% to $19.4 million in 2024, then gained by 17.03% to $22.7 million in 2025, then fell by 3.14% to $22.0 million in 2026.
• Business Quant data shows IRMD's Revenue at $22.0 million in Q1 2026, $22.7 million in Q4 2025, and $21.2 million in Q3 2025.